GP Pharm SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:Europe

Author(s):

Product Code:GDPH136436D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

November 2018

Total pages

18

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insipidus; endometriosis, women fertility and precocious puberty, among others. It provides products for acromegaly and gastro esophageal variceal bleed; acute hemorrhages of the upper gastro enteric tract; colorectal cancer; ovarian, lung, pancreas and metastatic breast cancers; and for preventing uterine atony following the infant delivery through caesarean section, among others. GP Pharm is developing its pre-clinical candidates in the areas of oncology, central nervous system disorders and musculoskeletal disorders. The company also offers contract development and contract manufacturing of pharmaceutical injectables for sterile drug products. The company has a manufacturing facility at Catalonia, Barcelona, and others. GP Pharm is headquartered in Barcelona, Spain.

GP Pharm SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

GP Pharm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

GP Pharm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

GP Pharm SA, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Hemispherx Biopharma Enters into Distribution Agreement with GP Pharm for Ampligen 10

Licensing Agreements 11

PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 11

Hikma Pharma Enters into Licensing and Supply Agreement with GP Pharm 12

Lee's Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 13

Hikma Pharma Enters Into Licensing Agreement With GP Pharm For Lutrate 1 Month 14

GP Pharm SA-Key Competitors 15

GP Pharm SA-Key Employees 16

GP Pharm SA-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List of Figure

List of Figures

GP Pharm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

GP Pharm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List of Table

List of Tables

GP Pharm SA, Pharmaceuticals & Healthcare, Key Facts 2

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

GP Pharm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

GP Pharm SA, Deals By Therapy Area, 2012 to YTD 2018 8

GP Pharm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Hemispherx Biopharma Enters into Distribution Agreement with GP Pharm for Ampligen 10

PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 11

Hikma Pharma Enters into Licensing and Supply Agreement with GP Pharm 12

Lee's Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 13

Hikma Pharma Enters Into Licensing Agreement With GP Pharm For Lutrate 1 Month 14

GP Pharm SA, Key Competitors 15

GP Pharm SA, Key Employees 16

GP Pharm SA, Other Locations 17

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022